Developer of a biotechnology platform designed to help scientists predict and mitigate drug toxicity earlier in the development process. Axiom (Biotechnology) is based in San Francisco, CA. Its last reported valuation was $121 million in Apr 2025. It has raised $30 million.
Last reported valuation
$121.0M
Oct 2026
Priced at
—
Total raised
$30.0M
Last round
—
Cap table — not yet on record
Axiom (Biotechnology)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Axiom (Biotechnology) with a free account
·The complete investor list: 14 names
·Watch Axiom (Biotechnology): the Monday email on marks, rounds and moves
